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In the study presented here experiments were performed using CAP to inactivate adenoviruses -non-enveloped double stranded DNA viruses -in solution. Due to their protein capsid, adenoviruses are among the most resistant viruses to inactivation. This is especially true for inactivation by UVC, changes in pH and moderate heat. The CAP source used is based on the Surface Micro Discharge (SMD) technology and is operated in air -thereby producing chemical products, of which significant fractions are identical to the ROS/RNS species produced by our own immune system in response to microbial attack. These species may dissolve in the embedding fluid of the viruses and inactivate the adenoviruses. Tests were conducted to determine the inactivation efficiency as well as the inhibition of replication due to the CAP treatment. Results are that a plasma treatment time of 240s is sufficient to inhibit replication and (using an end-point-dilution assay) that an up to six log reduction in adenovirus is achieved. This is not due to changes in the pH value of the medium, nor is it due to heating. The conclusion is that the dissolved ROS/RNS are likely to be responsible, making CAP a potentially very effective agent for control of viral infections. 
